Related Experiment Videos
Embedding of dithranol in lipid crystals
1Hydro Pharma AB, Malmö, Sweden.
Acta Dermato-Venereologica. Supplementum
|January 1, 1992
Summary
A novel lipid crystal cream base was developed for Dithranol, an antipsoriatic medication. This new formulation offers improved stability and ease of use, being nonstaining and easily washable.
Area of Science:
- Dermatology
- Pharmaceutics
- Materials Science
Background:
- Psoriasis is a chronic inflammatory skin condition.
- Dithranol is an effective topical treatment for psoriasis.
- Conventional Dithranol formulations can cause skin staining and are difficult to remove.
Purpose of the Study:
- To develop a new cream base for Dithranol formulations.
- To improve the stability and usability of Dithranol creams.
- To create an antipsoriatic cream that is nonstaining and easily washable.
Main Methods:
- Formulation of a cream base using lipid crystals of C12 and C14 monoglycerides.
- Incorporation of Dithranol into the developed cream base.
- Evaluation of cream properties including lipid melting point, Dithranol stability, washability, and staining potential.
Main Results:
- The cream base utilizes lipid crystals (C12 and C14 monoglycerides) that are solid at room temperature and melt at skin temperature.
- The formulated Dithranol cream demonstrated good stability of the active ingredient.
- The cream exhibited practical nonstaining properties and was easy to wash off the skin.
Conclusions:
- A novel lipid crystal cream base offers a promising approach for formulating Dithranol antipsoriatic treatments.
- This formulation enhances patient compliance by addressing issues of staining and washability.
- The developed cream provides a stable and user-friendly delivery system for Dithranol.